» Articles » PMID: 36400465

Coronavirus Disease-2019 and Implications on the Liver

Overview
Journal Clin Liver Dis
Specialty Gastroenterology
Date 2022 Nov 18
PMID 36400465
Authors
Affiliations
Soon will be listed here.
Abstract

The coronavirus disease-2019 (COVID-19) pandemic has had a large impact on patients with chronic liver disease (CLD) and liver transplantation (LT) recipients. Patients with advanced CLD are at a significantly increased risk of poor outcomes in the setting of severe acute respiratory syndrome coronavirus 2 infection. The pandemic has also considerably altered the management and care that is provided to patients with CLD, pre-LT patients, and LT recipients. Vaccination against COVID-19 protects patients with CLD and LT recipients from adverse outcomes and is safe in these patients; however, vaccine efficacy may be reduced in LT recipients and other immunosuppressed patients.

Citing Articles

COVID-19, Possible Hepatic Pathways and Alcohol Abuse-What Do We Know up to 2023?.

Michalak A, Lach T, Szczygiel K, Cichoz-Lach H Int J Mol Sci. 2024; 25(4).

PMID: 38396888 PMC: 10888568. DOI: 10.3390/ijms25042212.


Outcomes in Patients with Liver Dysfunction Post SARS-CoV-2 Infection: What Should We Measure?.

John N, Ibrahim B, Ebaid M, Saab S Hepat Med. 2023; 15:185-193.

PMID: 37850074 PMC: 10578169. DOI: 10.2147/HMER.S371507.


Liver Damage and COVID-19: At Least a "Two-Hit" Story in Systematic Review.

Montori M, Baroni G, Santori P, Di Giampaolo C, Ponziani F, Abenavoli L Curr Issues Mol Biol. 2023; 45(4):3035-3047.

PMID: 37185723 PMC: 10136465. DOI: 10.3390/cimb45040199.


The Latest Cellular and Molecular Mechanisms of COVID-19 on Non-Lung Organs.

Askari H, Rabiei F, Lohrasbi F, Ghadir S, Ghasemi-Kasman M Brain Sci. 2023; 13(3).

PMID: 36979225 PMC: 10046222. DOI: 10.3390/brainsci13030415.

References
1.
Cariani L, Orena B, Ambrogi F, Gambazza S, Maraschini A, Dodaro A . Time Length of Negativization and Cycle Threshold Values in 182 Healthcare Workers with Covid-19 in Milan, Italy: An Observational Cohort Study. Int J Environ Res Public Health. 2020; 17(15). PMC: 7432921. DOI: 10.3390/ijerph17155313. View

2.
Faruqui S, Okoli F, Olsen S, Feldman D, Kalia H, Park J . Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications. Am J Gastroenterol. 2021; 116(7):1414-1425. DOI: 10.14309/ajg.0000000000001264. View

3.
Lee A, Wong S, Chai L, Lee S, Lee M, Muthiah M . Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. BMJ. 2022; 376:e068632. PMC: 8889026. DOI: 10.1136/bmj-2021-068632. View

4.
Fan Z, Chen L, Li J, Cheng X, Yang J, Tian C . Clinical Features of COVID-19-Related Liver Functional Abnormality. Clin Gastroenterol Hepatol. 2020; 18(7):1561-1566. PMC: 7194865. DOI: 10.1016/j.cgh.2020.04.002. View

5.
Muhovic D, Bojovic J, Bulatovic A, Vukcevic B, Ratkovic M, Lazovic R . First case of drug-induced liver injury associated with the use of tocilizumab in a patient with COVID-19. Liver Int. 2020; 40(8):1901-1905. PMC: 7276916. DOI: 10.1111/liv.14516. View